NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to simplify and scale CAR-T production. The collaboration will test the system’s potential to reduce cost, footprint, and manual steps in a GMP setting.
The partnership strengthens NecstGen’s role in advancing cell therapy manufacturing and highlights Astraveus’ vision for decentralized, efficient production.
Read more: https://necstgen.com/necstgen-and-astraveus-collaborate-to-evaluate-benchtop-cell-factory-technology-for-scalable-car-t-manufacturing/
Last week, demissionary Minister of Social Affairs and Employment Eddy van Hijum paid a visit last week to the Post-COVID Expertise Center at Leiden University Medical Center...
Looking for something thoughtful to tune into this summer? Biopolis – Into the Microbiome is a new science podcast blending documentary storytelling with fiction to explore the...
Leiden Bio Science Park is taking concrete steps to increase biodiversity across its grounds, moving beyond ornamental landscaping to create habitats that support a wide range of...